Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

840
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
840
Aryldiazonium Salts to Azo Dyes: Diazo Coupling01:11

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

3.5K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para...
3.5K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

905
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
905
Antibiotic Selection00:57

Antibiotic Selection

58.7K
Overview
58.7K
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

337
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
337
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

820
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
820

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Magic bullets, magic shields, and antimicrobials in between.

Pharmaceutical science advances·2026
Same author

Aminoacyl-tRNA synthetase: A 'semiotic enzyme'.

European journal of medical genetics·2025
Same author

Integrating patient and public involvement during the COVID-19 pandemic: lessons from COVID-clinical neuroscience study.

Research involvement and engagement·2025
Same author

Characterisation of the fig-fig wasp holobiont.

Bio Systems·2024
Same author

A determination of pan-pathogen antimicrobials?

Medicine in drug discovery·2022
Same author

Broad-spectrum therapeutics: A new antimicrobial class.

Current research in pharmacology and drug discovery·2021

Related Experiment Video

Updated: Dec 10, 2025

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

8.2K

Azithromycin: The First Broad-spectrum Therapeutic.

Anton Firth1, Praveen Prathapan1

  • 1New Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK.

European Journal of Medicinal Chemistry
|September 2, 2020
PubMed
Summary

Azithromycin, a broad-spectrum antibiotic, shows potential for treating infectious threats like COVID-19. Its diverse pharmacology and history of repositioning warrant further investigation for pandemic preparedness.

Keywords:
AzithromycinBroad-spectrum therapeuticCOVID-19

More Related Videos

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.2K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.1K

Related Experiment Videos

Last Updated: Dec 10, 2025

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

8.2K
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.2K
An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.1K

Area of Science:

  • Infectious disease research
  • Pharmacology
  • Biodefense

Background:

  • The U.S. Department of Health and Human Services Strategic Plan for Biodefense Research highlights the need for broad-spectrum therapeutics.
  • Azithromycin, a macrolide, is a widely repositioned drug with diverse pharmacological activities.
  • Its inclusion in the RECOVERY trial but exclusion from the SOLIDARITY trial highlights ongoing debate regarding its efficacy in certain infectious diseases.

Purpose of the Study:

  • To review the antibiotic, antimalarial, and antiviral properties of azithromycin.
  • To contextualize azithromycin's history as a repositioned therapeutic.
  • To evaluate the clinical and socio-economic suitability of azithromycin for respiratory pandemics, including COVID-19.

Main Methods:

  • Literature review of azithromycin's pharmacological actions.
  • Analysis of azithromycin's inclusion/exclusion in major clinical trials (RECOVERY, SOLIDARITY).
  • Evaluation of clinical and socio-economic data relevant to respiratory pandemics.

Main Results:

  • Azithromycin exhibits broad-spectrum antibiotic, antimalarial, and antiviral activities.
  • The drug has a significant history of therapeutic repositioning within the macrolide class.
  • Its potential utility in respiratory pandemics, particularly COVID-19, is supported by its pharmacological profile.

Conclusions:

  • Azithromycin's multifaceted pharmacology makes it a candidate for biodefense and pandemic preparedness.
  • Further research and clinical evaluation are warranted to fully understand its role in managing respiratory infections like COVID-19.
  • A combinatorial mechanism of action model for azithromycin against COVID-19 pneumonia is proposed.